Rethinking approaches to analysis of global randomised controlled trials Post date 20 June 2025 ← GP Sarah Benn is suspended again as she calls for GMC to rethink how it deals with climate activists → Ticagrelor doubts: inaccuracies uncovered in key studies for AstraZeneca’s billion dollar drug